Morten Herholdt
Stock Analyst at HSBC
(2.52)
# 1,376
Out of 4,413 analysts
14
Total ratings
66.67%
Success rate
-3.07%
Average return
Main Sectors:
11 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GILD Gilead Sciences | Upgrades: Hold | $69 | $65.51 | +5.33% | 2 | Apr 24, 2024 | |
| JNJ Johnson & Johnson | Upgrades: Buy | $169 → $170 | $151.18 | +12.45% | 2 | Apr 18, 2024 | |
| BLUE bluebird bio | Maintains: Reduce | $2.31 → $1.02 | $0.91 | +12.17% | 2 | Mar 5, 2024 | |
| LH Laboratory Corporation of America Holdings | Initiates: Hold | $210 | $201.32 | +4.31% | 1 | Sep 6, 2023 | |
| ZTS Zoetis | Initiates: Buy | $230 | $158.50 | +45.11% | 1 | Sep 6, 2023 | |
| UNH UnitedHealth Group | Initiates: Hold | $540 | $484.11 | +11.54% | 1 | Sep 6, 2023 | |
| LIVN LivaNova | Initiates: Hold | $52 | $62.62 | -16.96% | 1 | Sep 6, 2023 | |
| IQV IQVIA Holdings | Initiates: Buy | $260 | $232.94 | +11.62% | 1 | Sep 6, 2023 | |
| BIIB Biogen | Initiates: Buy | $360 | $216.13 | +66.57% | 1 | Sep 6, 2023 | |
| AMGN Amgen | Initiates: Buy | $320 | $277.37 | +15.37% | 1 | Sep 6, 2023 | |
| ATNM Actinium Pharmaceuticals | Initiates: Buy | $12 | $7.78 | +49.10% | 1 | Sep 6, 2023 |
Gilead Sciences
Apr 24, 2024
Upgrades: Hold
Price Target: $69
Current: $65.51
Upside: +5.33%
Johnson & Johnson
Apr 18, 2024
Upgrades: Buy
Price Target: $169 → $170
Current: $151.18
Upside: +12.45%
bluebird bio
Mar 5, 2024
Maintains: Reduce
Price Target: $2.31 → $1.02
Current: $0.91
Upside: +12.17%
Laboratory Corporation of America Holdings
Sep 6, 2023
Initiates: Hold
Price Target: $210
Current: $201.32
Upside: +4.31%
Zoetis
Sep 6, 2023
Initiates: Buy
Price Target: $230
Current: $158.50
Upside: +45.11%
UnitedHealth Group
Sep 6, 2023
Initiates: Hold
Price Target: $540
Current: $484.11
Upside: +11.54%
LivaNova
Sep 6, 2023
Initiates: Hold
Price Target: $52
Current: $62.62
Upside: -16.96%
IQVIA Holdings
Sep 6, 2023
Initiates: Buy
Price Target: $260
Current: $232.94
Upside: +11.62%
Biogen
Sep 6, 2023
Initiates: Buy
Price Target: $360
Current: $216.13
Upside: +66.57%
Amgen
Sep 6, 2023
Initiates: Buy
Price Target: $320
Current: $277.37
Upside: +15.37%
Actinium Pharmaceuticals
Sep 6, 2023
Initiates: Buy
Price Target: $12
Current: $7.78
Upside: +49.10%